Derivados Quimicos SAU is an API manufacturer based in Spain. It holds 9 active US drug master files across a filed portfolio of 9 molecules. Its most recent recorded inspection, by US FDA, closed on 2 February 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Spain, Spain | 3003468553 |
| Molecule | Regulators | Docs |
|---|---|---|
| Meloxicam | SFDA (Saudi Arabia), US FDA | 2 |
| Butoconazole | US FDA | 1 |
| Cicletanine | US FDA | 1 |
| Cyclobenzaprine | US FDA | 1 |
| Fenofibrate | US FDA | 1 |
| Ketoconazole | US FDA | 1 |
| Milnacipran | US FDA | 1 |
| Racepinephrine | US FDA | 1 |
| Terconazole | US FDA | 1 |
Also appears on these molecule pages
Choose your molecules and target markets. Derivados Quimicos SAU comes back tiered against every other supplier able to file there.
Start for free